(Total Views: 487)
Posted On: 05/19/2025 12:19:46 PM
Post# of 155734
Nice find by My69z.
Here's the link:
https://www.businesswire.com/news/home/202411...ce-Q1-2025
But I think it seems the opposite of the MOA employed in our trial.
"Patients with low PD-L1 expression treated with Multikine in the target population had a 5-year survival of 73% vs. 45% in the control group"
Here's the link:
https://www.businesswire.com/news/home/202411...ce-Q1-2025
But I think it seems the opposite of the MOA employed in our trial.
"Patients with low PD-L1 expression treated with Multikine in the target population had a 5-year survival of 73% vs. 45% in the control group"
(3)
(0)
